Number of Shares
1.04 Mil
Current Holdings Value*
$11.41 Mil
% of Portfolio
1.29%
Total Estimate Gain
$82,872.80
% of Total Estimate Gain
0.66%

General Catalyst Group Management, LLC's Maze Therapeutics Inc Holding Summary

As of 2025-03-31, General Catalyst Group Management, LLC held 1.04 Mil shares of Maze Therapeutics Inc(MAZE), totaling $11.41 Mil. This investment constitutes 1.29% of their stock portfolio, and General Catalyst Group Management, LLC now holds 2.37% of the outstanding Maze Therapeutics Inc(MAZE) stock.

The initial trade took place in 2025Q1. And since then General Catalyst Group Management, LLC has made 1 purchases of MAZE, at an average price of $12.04, for a total of 1.04 Mil shares. Based on historical transaction data and MAZE's current price of $12.12, General Catalyst Group Management, LLC's estimated gain on his MAZE holdings is $82,872.80, reflecting a 0.66% gain to date.

General Catalyst Group Management, LLC MAZE ($12.12) Holding Chart

General Catalyst Group Management, LLC MAZE ($12.12) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1